22052-Solid Tumors-NA-56

Solid Tumors

A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)

  • Details

ClinicalTrials.gov ID: NCT05103358
Diagnosis Type: NA
USOR Number:

  • Address

4715 Arapahoe Avenue
Boulder, CO 80303
P: (303) 385-2000

Search by practice name, trial titles, indicators and specific disease types.